NORTH BETHESDA, MD, October 24, 2019 – The Board of Directors of the Foundation for the National Institutes of Health (FNIH) has elected lawyer and business leader Julie Bell Lindsay as its newest member. The FNIH Board elected Ms. Lindsay on May 23, 2019 and her appointment took effect on October 24, 2019.

“We are delighted to welcome Julie as our newest Board member,” said Steven M. Paul, M.D., Chairman of the FNIH Board. “Along with her vast experience in the corporate world, Julie brings with her a passion to advance the mission of the Foundation, as demonstrated through her outstanding work as Co-Chair of the Host Committee for the FNIH Award Ceremony for the last couple of years. We look forward to continuing our work with Julie to advance lifesaving biomedical research for the benefit of patients worldwide.”

With more than two decades of experience in law and business, Ms. Lindsay serves as the Executive Director at the Center for Audit Quality (CAQ), a not-for-profit, non-partisan organization which advocates on behalf of the public company auditing profession. Prior to her time at CAQ, Lindsay served as Managing Director & Deputy Head of Global Regulatory Affairs at Citigroup Inc. and as Counsel for Hogan Lovells. In addition, among other endeavors, she served as Counsel to Commissioner Cynthia Glassman at the U.S. Securities and Exchange Commission. Ms. Lindsay holds a B.A. in political science from The Ohio State University as well as a J.D. from Vanderbilt Law School.

“I know from personal experience the incredible work of the NIH and the beacon of hope it can provide for patients globally,” said Ms. Lindsay. “I am honored to join the FNIH Board of Directors and work with this great Foundation to further support biomedical research that can improve the quality of – and save – people’s lives.”

For more information about the FNIH Board of Directors, please visit fnih.org/about/directors.

About the Foundation for the National Institutes of Health
The Foundation for the National Institutes of Health creates and manages alliances with public and private institutions in support of the mission of the NIH, the world’s premier medical research agency. The Foundation, also known as the FNIH, works with its partners to accelerate biomedical research and strategies against diseases and health concerns in the United States and across the globe. The FNIH organizes and administers research projects; supports education and training of new researchers; organizes educational events and symposia; and administers a series of funds supporting a wide range of health issues. Established by Congress in 1990, the FNIH is a not-for-profit 501(c)(3) charitable organization. For additional information about the FNIH, please visit fnih.org.